Rebecca Bearden

Rebecca Bearden currently serves as the Sr. Director of Regulatory Operations at Asklepios BioPharmaceutical, Inc. since February 2022, where responsibilities include the planning and implementation of a global Regulatory Information Management (RIM) system and providing strategic submission guidance for initial INDs. Previously, Rebecca held leadership roles at Apellis Pharmaceuticals and Tessa Therapeutics Ltd, managing global submission operations and regulatory processes. With over a decade of experience at Shionogi Inc., Rebecca progressed from Regulatory Affairs Submissions Associate to Associate Director, overseeing numerous NDA and MAA submissions and implementing a global electronic document management system. A graduate of Pensacola Christian College with a Bachelor of Arts in History, Rebecca has demonstrated a consistent focus on improving regulatory submission efficiencies and team mentoring throughout a diverse career in regulatory affairs.